Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? [Yahoo! Finance]
Korro Bio, Inc. (KRRO)
Company Research
Source: Yahoo! Finance
This compares to the stock's 45.9% gain over the past four weeks. Korro Bio's stock price gain can be attributed to increasing investor confidence in Korro's pipeline diversification, particularly the emergence of KRRO-121 as a meaningful second asset, the first being KRRO-110, an RNA-editing therapeutic candidate using the OPERA platform. KRRO-121 is a subcutaneously administered, GalNAc-conjugated RNA-editing therapy designed to generate a de novo protein variant, with a first-in-human regulatory filing expected in the second half of 2026. Additionally, Korro is shifting its AATD program to a GalNAc-conjugated construct with development candidate nomination planned for 1H 2026, while advancing additional liver-targeted, subcutaneous GalNAc programs in cardiometabolic indications. This company is expected to post quarterly loss of $1.86 per share in its upcoming report, which represents a year-over-year change of +17.7%. Revenues are expected to be $1.5 million, down 33.9% from t
Show less
Read more
Impact Snapshot
Event Time:
KRRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRRO alerts
High impacting Korro Bio, Inc. news events
Weekly update
A roundup of the hottest topics
KRRO
News
- Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- Korro Announces Oversubscribed $85 Million Private Placement [Yahoo! Finance]Yahoo! Finance
- Korro Announces Oversubscribed $85 Million Private PlacementGlobeNewswire
- Korro to Present at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
KRRO
Earnings
- 3/12/26 - Miss
KRRO
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/23/26 - Form EFFECT
- 3/20/26 - Form 424B5
- KRRO's page on the SEC website